Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Laboratory tests during direct oral anticoagulant treatment? No.

Literature DB >> 23686689

Laboratory tests during direct oral anticoagulant treatment? No.

Giovanni Di Minno¹, Elena Ricciardi, Antonella Scalera.

Abstract

Mesh：

Substances：
Anticoagulants

Year: 2013 PMID： 23686689 DOI： 10.1007/s11739-013-0948-4

Source DB: PubMed Journal: Intern Emerg Med ISSN： 1828-0447 Impact factor: 3.397

× No keyword cloud information.

20 in total

Review 1. Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants.

Authors: D Garcia; Y C Barrett; E Ramacciotti; J I Weitz
Journal: J Thromb Haemost Date: 2013-02 Impact factor: 5.824

2. Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban.

Authors: J Harenberg; S Marx; C Weiss; R Krämer; M Samama; S Schulman
Journal: J Thromb Haemost Date: 2012-07 Impact factor: 5.824

3. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.

Authors: Jonathan Douxfils; François Mullier; Séverine Robert; Christian Chatelain; Bernard Chatelain; Jean-Michel Dogné
Journal: Thromb Haemost Date: 2012-03-22 Impact factor: 5.249

4. Do new oral anticoagulants require laboratory monitoring? The clinician point of view.

Authors: Meyer Michel Samama; Céline Guinet; Lena Le Flem
Journal: Thromb Res Date: 2012-10 Impact factor: 3.944

5. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.

Authors: Tomas L Lindahl; Fariba Baghaei; Inger Fagerberg Blixter; Kerstin M Gustafsson; Lennart Stigendal; Margareta Sten-Linder; Karin Strandberg; Andreas Hillarp
Journal: Thromb Haemost Date: 2010-11-23 Impact factor: 5.249

6. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

Authors: A Hillarp; F Baghaei; I Fagerberg Blixter; K M Gustafsson; L Stigendal; M Sten-Linder; K Strandberg; T L Lindahl
Journal: J Thromb Haemost Date: 2011-01 Impact factor: 5.824

Review 7. Thromboprophylaxis in the oldest old with atrial fibrillation: between Scylla and Charybdis.

Authors: Pier Mannuccio Mannucci
Journal: Eur J Intern Med Date: 2013-03-15 Impact factor: 4.487

8. Determination of rivaroxaban--a novel, oral, direct Factor Xa inhibitor--in human plasma by high-performance liquid chromatography-tandem mass spectrometry.

Authors: G Rohde
Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2008-07-23 Impact factor: 3.205

Review 9. Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients.

Authors: Matteo Nicola Dario Di Minno; Anna Russolillo; Alessandro Di Minno; Marina Camera; Alessandro Parolari; Elena Tremoli
Journal: Expert Opin Emerg Drugs Date: 2013-03 Impact factor: 4.191

10. Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratories.

Authors: Tuukka A Helin; Anja Pakkanen; Riitta Lassila; Lotta Joutsi-Korhonen
Journal: Clin Chem Date: 2013-02-01 Impact factor: 8.327

6 in total

1. Direct inhibitors of thrombin and factor Xa: the importance of laboratory skills.

Authors: Francesco Marongiu; Doris Barcellona
Journal: Intern Emerg Med Date: 2013-12-25 Impact factor: 3.397

Review 2. The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures.

Authors: Armando Tripodi; Francesco Marongiu; Marco Moia; Gualtiero Palareti; Vittorio Pengo; Daniela Poli; Domenico Prisco; Sophie Testa; Maria Zanazzi
Journal: Intern Emerg Med Date: 2018-04-26 Impact factor: 3.397